Carol A. Nacy
Founder and Chief Executive Officer, Sequella, Inc.
Dr. Carol A. Nacy is a founder and the Chief Executive Officer of Sequella, Inc. This privately-held pharmaceutical company discovers and develops effective treatments for life-threatening infectious diseases. Sequella has ongoing research collaborations with pharmaceutical companies and academic centers for the development of new drugs for neglected diseases.
Prior to Sequella, Dr. Nacy was EVP and Chief Scientific Officer at EntreMed, Inc. She left EntreMed in November 1996 to establish Sequella, Inc. and was part-time Chief Scientific Officer for Anergen, Inc., a California company focused on autoimmune diseases.
Dr. Nacy has been a member of the Board of Directors of multiple for-profit companies and non-profit agencies, including KGI. She also serves on several committees in global health organizations.
Prior to her business experience, Dr. Nacy was a career scientist and science manager for 17 years at the Walter Reed Army Institute of Research, where she studied tropical infectious diseases. She has published over 169 scientific papers and books to date.
She earned her A.B., M.S., and Ph.D. from the Catholic University of America in Washington, DC.